Scientists test Next-Gen mRNA shot against future flu pandemics
NCT ID NCT06602531
Summary
This was the first human study of a new type of mRNA flu vaccine designed to protect against potential future flu pandemics. Researchers tested three different doses in 212 healthy adults to see how safe it was and if it triggered a good immune response. They compared the new vaccine to standard, already-approved flu shots to help decide the best dose for future development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Tekton Research
Longmont, Colorado, 80501, United States
-
Velocity Clinical Research
La Mesa, California, 91942, United States
-
Velocity Clinical Research
San Bernardino, California, 92408, United States
Conditions
Explore the condition pages connected to this study.